[Federal Register Volume 59, Number 183 (Thursday, September 22, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-23376]
[[Page Unknown]]
[Federal Register: September 22, 1994]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Request for Nominations for Members on Public Advisory
Committees; Science Board to the Food and Drug Administration
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is requesting
nominations for members to serve on the Science Board to the Food and
Drug Administration (the board). Nominations will be accepted for
current vacancies and vacancies that will or may occur on the board
during the next 18 months.
FDA has a special interest in ensuring that women, minority groups,
and individuals with disabilities are adequately represented on
advisory committees and, therefore, extends particular encouragement to
nominations for appropriately qualified female, minority, or physically
disabled candidates. Final selections from among qualified candidates
for each vacancy will be determined by the expertise required to meet
specific agency needs and in a manner to ensure appropriate balance of
membership.
DATES: Nominations should be received by October 24, 1994.
ADDRESSES: All nominations and curricula vitae from academia, industry,
and government representatives for membership, except for general
public representatives (consumer-nominated members), should be sent to
Zelma S. Rein (address below). All nominations for general public
representatives (consumer-nominated members) should be sent to Susan K.
Meadows (address below).
FOR FURTHER INFORMATION CONTACT:
Regarding all nominations for membership, except for general public
representatives: Zelma S. Rein, Office of the Commissioner (HF-33),
Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857,
301-443-5839.
Regarding all nominations for general public representatives: Susan
K. Meadows, Office of Consumer Affairs (HFE-40), Food and Drug
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-443-5006.
SUPPLEMENTARY INFORMATION: FDA is requesting nominations for members to
serve on the board for the following vacancies: Two vacancies
immediately, four vacancies occurring December 31, 1994, and three
vacancies occurring December 31, l995.
Function
The function of the board is to provide advice primarily to the
agency's Senior Science Advisor and, as needed, to the Commissioner of
Food and Drugs and other appropriate officials on specific complex and
technical issues as well as emerging issues within the scientific
community in academia and industry. Additionally, the board provides
advice to the agency on keeping pace with technical and scientific
evolutions in the field of regulatory science, on formulating an
appropriate research agenda, and on upgrading its scientific and
research facilities to keep pace with these changes. The board also
provides the means for critical review of agency sponsored intramural
and extramural scientific research programs.
Criteria for Members
Persons nominated for membership from academia, industry, and
government representatives shall be knowledgeable in the fields of
chemistry, pharmacology, toxicology, clinical research, and other
scientific disciplines. The term of office is up to 4 years, depending
on the appointment date.
General Public Representatives (Consumer-nominated Members)
FDA currently attempts to place members on advisory committees who
are nominated by consumer organizations. These members are recommended
by a consortium of 12 consumer organizations that has the
responsibility for screening, interviewing, and recommending consumer-
nominated candidates with appropriate scientific credentials.
Candidates are sought who are aware of the consumer impact of committee
issues, but who also possess enough technical background to understand
and contribute to the committee's work. The agency notes, however, that
for some advisory committees, it may require such nominees to meet the
same technical qualifications and specialized training required of
other expert members of the committee. The term of office for these
members is up to 4 years, depending on the appointment date.
Nominations are invited for consideration for membership as openings
become available.
Nomination Procedures
Any interested person may nominate one or more qualified persons
for membership on the board. Nominations shall state that the nominee
is aware of the nomination, is willing to serve as a member of the
board, and appears to have no conflict of interest that would preclude
board membership. Potential candidates will be asked by FDA to provide
detailed information concerning such matters as financial holdings,
consultancies, and research grants or contracts in order to permit
evaluation of possible sources of conflict of interest.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.
Dated: September 14, 1994.
Linda A. Suydam,
Interim Deputy Commissioner for Operations.
[FR Doc. 94-23376 Filed 9-21-94; 8:45 am]
BILLING CODE 4160-01-F
